Physician profile
Sameer Gupta
NPI 1669638508
$19,540.40
in general payments reported to CMS, 2019-2025
8 companies · $1,656 in 2025
The $1,656 reported for 2025 was more than what 87% of Nephrology (Internal Medicine) providers received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $36.50 · 2021: $530 · 2022: $16K · 2023: $1,146 · 2024: $53.53 · 2025: $1,656.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,668 · Food and Beverage: $188.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,667.50 |
| Food and Beverage | $187.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $19,244.52 | 2020-2025 | Enhertu, Injectafer |
| Abbott Laboratories | $119.82 | 2021 | |
| Pharmacyclics LLC, An Abbvie Company | $73.47 | 2022-2023 | Imbruvica |
| Janssen Biotech, INC. | $31.61 | 2023 | |
| Beigene USA, INC. | $22.21 | 2020 | |
| Nxstage Medical, INC. | $20.64 | 2021 | |
| Beone Medicines USA, INC. | $15.91 | 2025 | Tevimbra |
| Alnylam Pharmaceuticals INC. | $12.22 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sameer Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.